• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER FLEX 35 VASCULAR SELF-EXPANDING STENT; NIO STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER FLEX 35 VASCULAR SELF-EXPANDING STENT; NIO STENT, ILIAC Back to Search Results
Catalog Number ZFV6-80-9-4.0
Device Problems Premature Activation (1484); Device Damaged Prior to Use (2284)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/20/2022
Event Type  malfunction  
Event Description
Product released automatically when opened the package."as per cc form": when the doctor opened the package, he noticed that the stent was loose in the package.No one had touched the release system and the red locking pin was also normally in the system.A section of the device did not remain inside the patient¿s body.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.No contact with patient.
 
Manufacturer Narrative
Pma/510(k) # p050017/s006.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Manufacturer Narrative
Pma/510(k) # p050017/s006 investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Supplemental mdr being submitted due to lab evaluation completed on 20-june-2022 lab evaluation 20th june : visual inspection red safety tab returned in place stent returned separately intact.Functional inspection 0.035'' wire guide passed through device with no issue.Device flushed as intended.
 
Manufacturer Narrative
Pma/510(k) # p050017/s006.Device evaluation the zfv6-80-9-4.0 device of lot number c1899061 involved in this complaint was returned for evaluation, with the original packaging.The packaging was open on receipt.With the information provided, a physical examination and document-based investigation was conducted.Lab evaluation the device related to this occurrence underwent a laboratory evaluation on the (b)(6)2022.Refer to attachments ¿zilver lab evaluations attendance (b)(6) 2022¿ for lab attendance.On evaluation of the device, it was found that the red safety tab was returned in place.The stent was returned separately intact.No other defects were found.The device flushes as intended and a 0.035¿ wire guide passed through the device with no issue.Document review prior to distribution zfv6-80-9-4.0 devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zfv6-80-9-4.0 of lot number c1899061 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records, confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1899061.There is no evidence to suggest the user did not follow the instructions for use, ifu0058.Root cause review a definitive root cause could not be determined from the available information.A possible root cause could be attributed to damage to the device caused by impact during shipping.It is possible that the device was subjected to impact during transportation in its original packaging, which may have caused components in the handle of the device to become damaged/cracked, which may have led to or contributed to the deployment of the stent.Summary complaint is confirmed as the failure was verified in the laboratory.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.The damaged device was not used in any procedure.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental mdr being submitted due to completed investigation on 05-aug-2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER FLEX 35 VASCULAR SELF-EXPANDING STENT
Type of Device
NIO STENT, ILIAC
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key14712495
MDR Text Key294574206
Report Number3001845648-2022-00361
Device Sequence Number1
Product Code NIO
UDI-Device Identifier10827002519173
UDI-Public(01)10827002519173(17)250104(10)C1899061
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberZFV6-80-9-4.0
Device Lot NumberC1899061
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/20/2022
Event Location Hospital
Initial Date Manufacturer Received 05/20/2022
Initial Date FDA Received06/16/2022
Supplement Dates Manufacturer Received05/20/2022
05/20/2022
Supplement Dates FDA Received07/18/2022
09/01/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-